Regal Assets Analytics

SELB

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-10-20T14:21:50-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , , , , , , , , |

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

Selecta Licenses Away Promising Gout Drug; SanaCurrents Suspending Coverage

By |2020-10-20T14:49:51-04:00June 12th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , |

After the market closed on June 11, Selecta Biosciences, Inc. [...]

Selecta Biosciences (SELB) Probability Sentiment

By |2020-04-19T10:24:51-04:00February 22nd, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Selecta Biosciences, Inc. (NASDAQ:SELB) Probability Sentiment [...]